Yu Yao

2.2k total citations
62 papers, 1.6k citations indexed

About

Yu Yao is a scholar working on Molecular Biology, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Yu Yao has authored 62 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Molecular Biology, 20 papers in Oncology and 16 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Yu Yao's work include Cancer-related molecular mechanisms research (10 papers), Lung Cancer Treatments and Mutations (7 papers) and RNA Interference and Gene Delivery (6 papers). Yu Yao is often cited by papers focused on Cancer-related molecular mechanisms research (10 papers), Lung Cancer Treatments and Mutations (7 papers) and RNA Interference and Gene Delivery (6 papers). Yu Yao collaborates with scholars based in China, United States and United Kingdom. Yu Yao's co-authors include Aili Suo, Junmin Qian, Weijun Xu, Tao Tian, Wangxiao He, Jin Yan, Zhiping Ruan, Yaping Wang, Guanghui Hou and Jinlei Wang and has published in prestigious journals such as Angewandte Chemie International Edition, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Yu Yao

58 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Yu Yao China	24	743	430	378	326	300	62	1.6k
Tae Sup Lee South Korea	24	842 1.1×	464 1.1×	346 0.9×	236 0.7×	304 1.0×	81	2.0k
Rita Mendes Portugal	11	590 0.8×	414 1.0×	415 1.1×	301 0.9×	229 0.8×	16	1.4k
Jingbo Wu China	25	708 1.0×	452 1.1×	491 1.3×	435 1.3×	437 1.5×	83	2.0k
Lacey R. McNally United States	27	668 0.9×	819 1.9×	341 0.9×	193 0.6×	358 1.2×	79	2.0k
Marta Truffi Italy	24	704 0.9×	394 0.9×	379 1.0×	220 0.7×	405 1.4×	69	1.7k
Yojiro Maehata Japan	16	748 1.0×	454 1.1×	371 1.0×	266 0.8×	339 1.1×	32	1.9k
Anubhab Mukherjee United States	12	688 0.9×	609 1.4×	371 1.0×	163 0.5×	450 1.5×	18	1.8k
Yun Zhou China	24	857 1.2×	400 0.9×	186 0.5×	369 1.1×	174 0.6×	66	1.6k
Chun‐Wei Peng China	29	1.0k 1.4×	396 0.9×	660 1.7×	525 1.6×	216 0.7×	64	2.3k

Countries citing papers authored by Yu Yao

Since Specialization

Citations

This map shows the geographic impact of Yu Yao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yu Yao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yu Yao more than expected).

Fields of papers citing papers by Yu Yao

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yu Yao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yu Yao. The network helps show where Yu Yao may publish in the future.

Co-authorship network of co-authors of Yu Yao

This figure shows the co-authorship network connecting the top 25 collaborators of Yu Yao. A scholar is included among the top collaborators of Yu Yao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yu Yao. Yu Yao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Yao, Yu, et al.. (2025). Automatic machine learning accurately predicts the efficacy of immunotherapy for patients with inoperable advanced non-small cell lung cancer using a computed tomography-based radiomics model. Diagnostic and Interventional Radiology. 31(2). 130–140. 2 indexed citations

Yu, Changdong, et al.. (2025). Real-time 6-DoF pose estimation for UUVs based on advanced CNN architecture with adaptive loss constraints. Ocean Engineering. 333. 121425–121425.

Yao, Yu, et al.. (2025). A novel HVEM-Fc recombinant protein for lung cancer immunotherapy. Journal of Experimental & Clinical Cancer Research. 44(1). 62–62. 3 indexed citations

Chu, Tianqing, Xiaorong Dong, Huijuan Wang, et al.. (2024). Heterogeneity in advanced pulmonary sarcomatoid carcinoma and its efficacy to immune checkpoint inhibitors. European Journal of Cancer. 209. 114260–114260. 2 indexed citations

Zhang, Hao, Chieh‐Lin Jerry Teng, Yu Yao, et al.. (2024). MRI-based radiomics models for noninvasive evaluation of lymphovascular space invasion in cervical cancer: a systematic review and meta-analysis. Clinical Radiology. 79(11). e1372–e1382. 1 indexed citations

Zhou, Qing, Lin Wu, Bo Jiang, et al.. (2023). Uliledlimab and toripalimab combination therapy in treatment naive advanced NSCLC: Phase 1b/2 clinical trial results using CD73 as a potential predictive biomarker.. Journal of Clinical Oncology. 41(16_suppl). 2570–2570. 4 indexed citations

Yao, Yu, Huaping Yang, Bo Zhu, et al.. (2023). Mutations in the MET tyrosine kinase domain and resistance to tyrosine kinase inhibitors in non-small-cell lung cancer. Respiratory Research. 24(1). 28–28. 10 indexed citations

Jia, Xi, Xinru Li, Yuanbo Wang, et al.. (2022). The role of [99mTc]Tc-HFAPi SPECT/CT in patients with malignancies of digestive system: first clinical experience. European Journal of Nuclear Medicine and Molecular Imaging. 50(4). 1228–1239. 25 indexed citations

Yao, Yu, Yafeng Ma, Qiuxiang Ou, et al.. (2022). Characterizing kinase intergenic-breakpoint rearrangements in a large-scale lung cancer population and real-world clinical outcomes. ESMO Open. 7(2). 100405–100405. 3 indexed citations

10.

Jiang, Aimin, Na Liu, Huan Gao, et al.. (2020). <p>Nosocomial Infections in Gastrointestinal Cancer Patients: Bacterial Profile, Antibiotic Resistance Pattern, and Prognostic Factors</p>. Cancer Management and Research. Volume 12. 4969–4979. 8 indexed citations

11.

Jiang, Aimin, Na Liu, Rui Zhao, et al.. (2020). Clinical outcomes and prognostic factors in bloodstream infections due to extended-spectrum β-lactamase-producing Enterobacteriaceae among patients with malignancy: a meta-analysis. Annals of Clinical Microbiology and Antimicrobials. 19(1). 53–53. 10 indexed citations

12.

Xu, Weijun, Junmin Qian, Guanghui Hou, et al.. (2018). PEGylated hydrazided gold nanorods for pH-triggered chemo/photodynamic/photothermal triple therapy of breast cancer. Acta Biomaterialia. 82. 171–183. 58 indexed citations

13.

Wang, Jing, Zhiyan Liu, Tinghua Hu, et al.. (2017). Nrf2 promotes progression of non-small cell lung cancer through activating autophagy. Cell Cycle. 16(11). 1053–1062. 36 indexed citations

14.

Wang, Yu, Jing Li, François X. Claret, et al.. (2017). Autophagy in the “inflammation-carcinogenesis” pathway of liver and HCC immunotherapy. Cancer Letters. 411. 82–89. 58 indexed citations

15.

Li, Qing, Tao Wu, Jing Li, et al.. (2017). Angiogenesis inhibitors for the treatment of small cell lung cancer (SCLC). Medicine. 96(13). e6412–e6412. 15 indexed citations

16.

Song, Yongchun, Jianli Zhang, Tao Tian, et al.. (2016). SET7/9 inhibits oncogenic activities through regulation of Gli-1 expression in breast cancer. Tumor Biology. 37(7). 9311–9322. 25 indexed citations

17.

Song, Yongchun, Tao Tian, Xiao Fu, et al.. (2015). GATA6 is overexpressed in breast cancer and promotes breast cancer cell epithelial–mesenchymal transition by upregulating slug expression. Experimental and Molecular Pathology. 99(3). 617–627. 32 indexed citations

18.

Hu, Tinghua, Yu Yao, Shuo Yu, et al.. (2014). SDF-1/CXCR4 promotes epithelial–mesenchymal transition and progression of colorectal cancer by activation of the Wnt/β-catenin signaling pathway. Cancer Letters. 354(2). 417–426. 119 indexed citations

19.

Zhao, Ling, Yu Yao, Jia Han, et al.. (2014). miR-638 Suppresses Cell Proliferation in Gastric Cancer by Targeting Sp2. Digestive Diseases and Sciences. 59(8). 1743–1753. 61 indexed citations

20.

Wang, Wenjuan, Yu Yao, Lili Jiang, et al.. (2013). Knockdown of Lymphoid Enhancer factor 1 Inhibits Colon Cancer Progression In Vitro and In Vivo. PLoS ONE. 8(10). e76596–e76596. 44 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact